期刊文献+

利多卡因胶浆和链霉蛋白酶联合应用在胃镜检查中的价值 被引量:5

The Value of Lidocaine Hydrochloride Mucilage Combined with Pronase in Gastroscopy
原文传递
导出
摘要 目的探讨链霉蛋白酶在胃镜检查中的作用。方法将在我院接受胃镜检查的门诊患者200例,随机分为研究组和对照组,每组100例。研究组于检查前15min口服链霉蛋白酶溶液及10ml利多卡因胶浆,对照组于检查前15min口服10ml利多卡因胶浆,比较两组胃镜检查时的视野清晰度、检查时间、微小病灶的观察情况。结果研究组与对照组比较,胃镜视野清晰度高(P<0.05)、检查时间短(P<0.05)、微小病变的检出率高(P<0.05),可提高胃部癌前病变的检出率。结论利多卡因胶浆联合链霉蛋白酶可应用于胃镜检查的准备,可以提高疾病的诊断率。 Objective To evaluate the clinical effect of pronasecombined withlidocaine mucilage in endoscopyexamination. Methods A total of 200 patients who accepted endoscopy were randomly assigned to research group and control group. The research group accepted oral pronase and lidocaine mucilage 10 ml 15 minutes before the endoscopy examination; while,the control group accepted oral lidocaine mucilage 10 ml 15 minutes before the procedure. The total checking time,image visibility scores,microlesion,were recorded. Results Compared with the control group,the research group have obviously improvements in the image visibility,the time of examinationand positive detection rates of microlecsion and precancerous lesion( P〈0. 05). Conclusion Premedication with pronase and lidocaine mucilage can reduce the procedure time and improve image visibility and increase the detection rates of micro-lesion,especially for the precancerous lesions.
出处 《潍坊医学院学报》 2016年第2期119-121,共3页 Acta Academiae Medicinae Weifang
关键词 胃镜检查 视野清晰度 链霉蛋白酶 Gastroscopy Visibility Pronase
  • 相关文献

参考文献9

  • 1McColl KE. Screening for early gastric cancer[ J]. Gut,2005,54 (6) : 740 - 742.
  • 2卫炜,戈之铮,高云杰,顾静莉,胡运彪,萧树东.胶囊内镜检查对消化道转运时间的影响[J].上海交通大学学报(医学版),2006,26(5):519-522. 被引量:48
  • 3Kuo CH, Sheu BS, Kao AW, et al. A defoaming agent shouldbe used witbpronasepremedieation to improve visibilityinuppergastrointestinal endoscopy[ J]. Endoscopy,2002,34:531 - 534.
  • 4Tan YK, Fielding JW. Early diagnosis of early gastric cancer[ J ]. Eur J Gastroenterol Hepatol,2006,18 ( 8 ) : 821 - 829.
  • 5Sue-Ling HM, Martin I, Griffith J, et al. Early gastric cancer:46 cases treated in one surgical department [ J]. Gut, 1992,33 ( 10 ) : 1318 - 1322.
  • 6Tan YK, Fielding JW. Early T diagnosis of early gastric cancer [ J ]. Eur J Gastroenterol Hepato1,2006,18 ( 8 ) :821 - 829.
  • 7Banerjee B, Parker J, Waits W, et al. Effectiveness of preproceduresim- ethicone drink in improving visibility during esophagogastroduodenos- copy: a double-blind, randomized study [ J ]. J Clin Gastroenterol , 1992,15(3) :264 -265.
  • 8Ida K, Okuda J, Nakazawa S, et al. Clinical evaluation of premedica- tion with KPD (Pronase) in astroendoscopy-placebo-controlled double blind study in dye scattering endoscopy[ J]. Clin Rep, 1991,25:1793 - 1804.
  • 9Kasugai T. Prognosis of early gastric cancer[ J]. Gastroenterology, 1970,58(3) :429 -431.

二级参考文献21

  • 1柯美云,张秀兰.不透X线标志物的胃肠通过时间测定及其临床应用[J].大肠肛门病外科杂志,1997,3(3):33-34. 被引量:16
  • 2Nolan DJ,Traill ZC.The current role of the barium examination of the small intestine[J].Clin Radol,1997,52 (11):809-820.
  • 3Swain CP.The role of enteroscopy in clinical practice[J].Gastrointest Endosc Clin N Am,1999,9:135 -144.
  • 4Marmo R,Rotondano G,Piscopo R,et al.Capsule endoscopy versus enteroclysis in the detection of small-bowel involvement in Crohn's disease:a prospective trial[J].Clin Gastroenterol Hepatol,2005,3(8):772 -776.
  • 5Liatsos C,Goulas S,Karagiannis S,et al.Diagnosis of small-bowel ischemic necrosis by capsule endoscopy[J].Gastrointest Endosc,2005,62(3):439-440.
  • 6Warwick Selby.Complete small-bowel transit in patients undergoing capsule endoscopy:determining factors and improvement with metoclopramide[J].Gastrointest Endosc,2005,61 (1):80-85.
  • 7Chan S,Chen G,Kalpakian M.Factors that delay transit time of wireless capsule endoscopy[J].Gastrointest Endosc,2004,59 (5):AB174.
  • 8Chan S,Wang J,Daniels JM.A retrospective evaluation of wireless capsule endoscopy:determination of factors that influence transit time[J].Gastrointest Endosc,2004,59 (5):AB175.
  • 9Castiglione F,Del Vecchio Blanco G,Rispo A,et al.Orocecal transit time and bacterial overgrowth in patients with Crohn's disease[J].J Clin Gastroenterol,2000,31(1):63-66.
  • 10Tursi A,Brandimarte G,Giorgetti G,et al.Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy[J].Eur J Gastroenterol Hepatol,2003,15(1):69-74.

共引文献47

同被引文献47

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部